The advantage of using low concentrations of two separate classes of drugs can be appreciated when we compare our data with those of Zheng et al[19], in which, they had to use a ten-fold higher concentration (100 nM) of anti-Ki-67 siRNA to inhibit tumor proliferation only by 45%. Here, MKI67 is linked to neoplasm.